Fungal infection in nail psoriasis

An existence to consider

https://doi.org/10.53730/ijhs.v6nS9.14044

Authors

  • Nadia Farooq Assistant Professor Dermatology, Baqai Medical University, Karachi Pakistan
  • Syeda Shahmoona Tirmizi Assistant Professor Dermatology, Hamdard Medical University, Karachi Pakistan
  • Maria Mansoor Assistant Professor Dermatology, Dow University of Health Sciences, Karachi
  • Saba Nasreen Assistant Professor Dermatology, Baqai Medical University, Karachi Pakistan
  • Sana Gul Consultant Dermatologist, Jinnah Medical and Dental College, Karachi Pakistan
  • Naseem Amin Dhedhi Consultant Family Medicine, Razi Alkhidmat Hospital, Islamabad Pakistan

Keywords:

Psoriatic nails, Onychomycosis, Frequency

Abstract

Introduction: Onychomycosis is a common superficial fungal infection of nail in both developed and developing countries. It may involve any component of the nail unit, including the nail matrix, the nail bed, or the nail plate. It represents up to 20.0% of all nail disorders. Its prevalence is estimated at 2 to 18 percentage worldwide and up to 48-percentage incidence by age 70. Onychomycosis can be caused by dermatophyte mold, yeasts and non dermatophyte mold. We planned this study to determine the frequency of onychomycosis in psoriatic nails to establish the local perspective as the international studies shows wide variation. Objective: To find the presence of fungal elements in nails of patients affected by psoriasis. Setting: Dermatology (OPD), Baqai Medical University. Duration: 06 months from 15th July 2022 - 15th Dec 2022. Design: Descriptive Cross-sectional study. Results: In this study, out of 96 cases, 32.29% (n=31) of patients were between 18-40 years and 67.71% (n=65) were between 41-70 years of age, mean+SD: 47.32+11.94 years.

Downloads

Download data is not yet available.

References

Alves N, Moreira TA, Malvino L, Rodrigue, JJ, Ranza R, Araújo LB et al. Onychomycosis in Psoriatic Patients with Nail Disorders: Aetiological Agents and Immunosuppressive Therapy. Dermatology research and practice. 2020:7209518.

Tabassum S, Rahman A, Awan S, Jabeen K, Farooqi J, Ahmed B, et al. Factors associated with onychomycosis in nail psoriasis: a multicenter study in Pakistan. Int J Dermatol. 2019:58(6):672-678.

Romaszkiewicz A, Bykowska B, Zabłotna M, Sobjanek M, Sławińska M, Nowicki RJ. The prevalence and etiological factors of onychomycosis in psoriatic patients. Advances in Dermatology. 2018:35(3):309-313.

A Tsentemeidou, T A Vyzantiadis, A Kyriakou, D Sotiriadis, A Patsatsi, “Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: results of a pilot study”. Mycoses. 2017:60(12):830–835.

Jendoubi F, Ben Lagha I, Rabhi F, Doss N, Mrabet A, Jaber K, et al. Nail Involvement in Psoriatic Patients and Association with Onychomycosis: Results from a Cross-Sectional Study Performed in a Military Hospital in Tunisia. Skin Appendage Disorders. 2019:5(5):299-303.

Grynszpan R, Barreiros G, Nascimento P M, Frasnelli F M, Aguinaga F, Camargo C, et al Coexistence of onychomycosis and nail psoriasis and its correlation with systemic treatment. Mycoses. 2021:64(9):1092-1097.

Klaassen K M, Dulak M G, van de Kerkhof P C, Pasch M C. The prevalence of onychomycosis in psoriatic patients: a systematic review. J Eur Acad Dermatol Venereol. 2014:28(5):533-41.

Haneke E. Differential Diagnosis of Nail Psoriasis and Onychomycoses: A Report Based on 40 Years of Specialised Nail Consultations. EMJ Dermatol. 2020:00008.

Lipner SR, Scher RK. Onychomycosis: Clinical overview and diagnosis. J Am Acad Dermatol. 2019:80(4):835-851.

Ventura A, Mazzeo M, Gaziano R, Galluzzo M, Bianchi L, Campione E. New insight into the pathogenesis of nail psoriasis and overview of treatment strategies. Drug design, development and therapy. 2017:11:2527–2535.

Gupta A K, Versteeg S G, Shear N H. Onychomycosis in the 21st Century: An Update on Diagnosis, Epidemiology, and Treatment. J Cutan Med Surg. 2017:21(6):525-539.

Gupta AK, Stec N, Summerbell RC, Shear NH, Piguet V, Tosti A, Piraccini BM. Onychomycosis: a review. J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1972-1990.

Lipner SR, Scher RK. Onychomycosis: Treatment and prevention of recurrence. J Am Acad Dermatol. 2019 Apr;80(4):853-867

Gupta AK, Venkataraman M, Talukder M. Onychomycosis in Older Adults: Prevalence, Diagnosis, and Management. Drugs Aging. 2022 Mar;39(3):191-198

Gupta C, Jongman M, Das S, Snehaa K, Bhattacharya SN, Seyedmousavi S, et al. Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India. Mycopathologia. 2016 Aug;181((7-8)):497–504

Babayani M, Salari S, Hashemi SJ, Ghasemi Nejad Almani P, Fattahi A. Onychomycosis due to dermatophytes species in Iran: prevalence rates, causative agents, predisposing factors and diagnosis based on microscopic morphometric findings. J Mycol Med. 2018 Mar;28((1)):45–50

Leibovici V, Hershko K, Ingber A, Westerman M, Leviatan-Strauss N, Hochberg M. Increased prevalence of onychomycosis among psoriatic patients in Israel. Acta Derm Venereol. 2008;88(1):31-3.

Peng Y-T, Yu R-T, Chen A-J, Wen Z-Y, Xu J, Huang K, Wang P. Predicting the Risk of Nail Involvement in Psoriasis Patients: Development and Assessment of a Predictive Nomogram. Diagnostics. 2023; 13(4):633

Reich, K. Approach to managing patients with nail psoriasis. J. Eur. Acad. Dermatol. Venereol. 2009, 23 (Suppl. 1), 15–21

Jiaravuthisan, M.M.; Sasseville, D.; Vender, R.B.; Murphy, F.; Muhn, C.Y. Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy. J. Am. Acad. Dermatol. 2007, 57, 1–27

Alves NCPOP, Moreira TA, Malvino LDS, Rodrigues JJ, Ranza R, de Araújo LB, Pedroso RDS. Onychomycosis in Psoriatic Patients with Nail Disorders: Aetiological Agents and Immunosuppressive Therapy. Dermatol Res Pract. 2020 May 2;2020

Gallo L, Cinelli E, Fabbrocini G, Vastarella M. A 15-year retrospective study on the prevalence of onychomycosis in psoriatic vs non-psoriatic patients: A new European shift from dermatophytes towards yeast. Mycoses. 2019 Aug;62(8):659-664

Kyriakou A, Zagalioti SC, Trakatelli MG, Fotiadou C, Apalla Z, Lazaridou E, Patsatsi A. Fungal Infections and Nail Psoriasis: An Update. J Fungi (Basel). 2022 Feb 3;8(2)

Chaowattanapanit S, Pattanaprichakul P, Leeyaphan C, Chaiwanon O, Sitthinamsuwan P, Kobwanthanakun W, Hanamornroongruang S, Bunyaratavej S. Coexistence of Fungal Infections in Psoriatic Nails and their Correlation with Severity of Nail Psoriasis. Indian Dermatol Online J. 2018 Sep-Oct;9(5):314-317

Chularojanamontri L, Pattanaprichakul P, Leeyaphan C, Suphatsathienkul P, Wongdama S, Bunyaratavej S. Overall Prevalence and Prevalence Compared among Psoriasis Treatments of Onychomycosis in Patients with Nail Psoriasis and Fungal Involvement. Biomed Res Int. 2021 Dec

Wang S, Song Y, Wan Z, Chen W, Wang R, Li R. Characterisation of the nail microbiome in psoriatic and nonpsoriatic patients with onychomycosis. Mycoses. 2022 Jan;65(1):35-44

Tsentemeidou A., Vyzantiadis T.-A., Kyriakou A., Sotiriadis D., Patsatsi A. Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: results of a pilot study. Mycoses. 2017;60(12):830–835

Published

09-03-2023

How to Cite

Farooq, N., Tirmizi, S. S., Mansoor, M., Nasreen, S., Gul, S., & Dhedhi, N. A. (2023). Fungal infection in nail psoriasis: An existence to consider. International Journal of Health Sciences, 6(S9), 4784–4794. https://doi.org/10.53730/ijhs.v6nS9.14044

Issue

Section

Peer Review Articles